Rapid risk assessment: Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae

risk assessment
Cite:
Citation Link

European Centre for Disease Prevention and Control. Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae – 12 June 2018.  Stockholm; ECDC; 2018. 

Copy citation to clipboard

This risk assessment will discuss CAZ-AVI resistance in brief, review the recent literature reporting resistance of CRE to CAZ-AVI, and assess the risk for the EU/EEA countries. It will outline options for appropriate detection of resistance and the correct and timely implementation of IPC measures to prevent spread of these highly resistant organisms within healthcare settings and across borders.

Related content

Publication

Rapid risk assessment: Outbreak of VIM-producing carbapenem-resistant Pseudomonas aeruginosa linked to medical tourism to Mexico

risk assessment -

News

Gonorrhoea: drug resistance compromises recommended treatment in Europe

news story -

News

Zoonoses: antimicrobial resistance shows no signs of slowing down

press release -

Publication

The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017

surveillance report -

News

Survey of healthcare workers’ knowledge and attitudes about antibiotics and antibiotic resistance

news story -